They compared the prevalence of thyroid cancer in patients with nodules vs patients without nodules. Overall, the finding of thyroid cancer varied significantly in the studies from 3.8 to 29.2%, with an average of 11.5%. When nodules were noted prior to surgery, 22.2% ultimately had thyroid cancer, compared to only 5% in patients who did not have nodules noted before surgery. The risk for thyroid cancer was similar if patients had more than one nodule compared to only one nodule.
WHAT ARE THE IMPLICATIONS OF THIS STUDY?
This study suggests that thyroid cancer is often found in patients with Graves’ disease who also have thyroid nodules and who are treated with surgery. However, there are some limitations to the study that need to be taken into consideration. All the studies looked back at the results of patients who had surgery and the presence of a concerning nodule may have played in the decision which patients ultimately went to surgery as treatment for their Graves’ disease. In addition, there is no information on how many of these cancers were what is called “microcarcinomas”, which are very common and are likely not to be clinically significant, or how many cancers were in glands that did not have a clinically apparent nodule. Still, this study suggests that if a nodule is present, surgery may be the best option for definitive treatment of Graves’ disease. Also, this does point out the need to evaluate nodules in patients with Graves’ disease and to biopsy nodules that have suspicious characteristics on ultrasound.
— Marjorie Safran, MD